255 related articles for article (PubMed ID: 11888533)
1. A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
Liu S; Schmitz C; Stampfer MJ; Sacks F; Hennekens CH; Lindpaintner K; Ridker PM
Atherosclerosis; 2002 Apr; 161(2):469-74. PubMed ID: 11888533
[TBL] [Abstract][Full Text] [Related]
2. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.
Eiriksdottir G; Bolla MK; Thorsson B; Sigurdsson G; Humphries SE; Gudnason V
Atherosclerosis; 2001 Nov; 159(1):187-92. PubMed ID: 11689220
[TBL] [Abstract][Full Text] [Related]
3. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.
Brousseau ME; O'Connor JJ; Ordovas JM; Collins D; Otvos JD; Massov T; McNamara JR; Rubins HB; Robins SJ; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1148-54. PubMed ID: 12117730
[TBL] [Abstract][Full Text] [Related]
5. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
[TBL] [Abstract][Full Text] [Related]
6. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
Ordovas JM; Cupples LA; Corella D; Otvos JD; Osgood D; Martinez A; Lahoz C; Coltell O; Wilson PW; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1323-9. PubMed ID: 10807749
[TBL] [Abstract][Full Text] [Related]
7. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
[TBL] [Abstract][Full Text] [Related]
8. The frequency of the cholesteryl ester transfer protein-TaqI B2 allele is lower in African Americans than in Caucasians.
Cuchel M; Wolfe ML; deLemos AS; Rader DJ
Atherosclerosis; 2002 Jul; 163(1):169-74. PubMed ID: 12048136
[TBL] [Abstract][Full Text] [Related]
9. HDL cholesterol and TaqIB cholesteryl ester transfer protein gene polymorphism in renal transplant recipients.
Radeau T; Vohl MC; Houde I; Lachance JG; Noël R; Després JP; Douville P; Bergeron J
Nephron; 2000 Apr; 84(4):333-41. PubMed ID: 10754410
[TBL] [Abstract][Full Text] [Related]
10. Human cholestryl ester transfer protein (TaqIB) polymorphism among Filipinos with cardiovascular risk factors.
Sy RG; Cutiongco EM; Punzalan FE; Santos RS; Geronimo FR; Tangco RV
J Atheroscler Thromb; 2007 Jun; 14(3):116-21. PubMed ID: 17587762
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
[TBL] [Abstract][Full Text] [Related]
12. Common cholesteryl ester transfer protein gene variation related to high-density lipoprotein cholesterol is not associated with decreased coronary heart disease risk after a 10-year follow-up in a Mediterranean cohort: Modulation by alcohol consumption.
Corella D; Carrasco P; Amiano P; Arriola L; Chirlaque MD; Huerta JM; Martínez C; Martinez-Camblor P; Molina E; Navarro C; Quirós JR; Rodríguez L; Sánchez MJ; Ortega-Azorín C; Ros E; Sala N; González CA; Moreno C
Atherosclerosis; 2010 Aug; 211(2):531-8. PubMed ID: 20398902
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of cholesteryl ester transfer protein TaqIB polymorphism and risk of myocardial infarction.
Cao M; Zhou ZW; Fang BJ; Zhao CG; Zhou D
Medicine (Baltimore); 2014 Nov; 93(26):e160. PubMed ID: 25474428
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.
Arca M; Montali A; Ombres D; Battiloro E; Campagna F; Ricci G; Verna R
Clin Genet; 2001 Nov; 60(5):374-80. PubMed ID: 11903340
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study.
Freeman DJ; Samani NJ; Wilson V; McMahon AD; Braund PS; Cheng S; Caslake MJ; Packard CJ; Gaffney D
Eur Heart J; 2003 Oct; 24(20):1833-42. PubMed ID: 14563342
[TBL] [Abstract][Full Text] [Related]
16. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.
Ikewaki K; Mabuchi H; Teramoto T; Yamada N; Oikawa S; Sasaki J; Takata K; Saito Y;
Metabolism; 2003 Dec; 52(12):1564-70. PubMed ID: 14669156
[TBL] [Abstract][Full Text] [Related]
17. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.
Dullaart RP; Sluiter WJ
Pharmacogenomics; 2008 Jun; 9(6):747-63. PubMed ID: 18518852
[TBL] [Abstract][Full Text] [Related]
18. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men.
Li TY; Zhang C; Asselbergs FW; Qi L; Rimm E; Hunter DJ; Hu FB
Am J Clin Nutr; 2007 Nov; 86(5):1524-9. PubMed ID: 17991668
[TBL] [Abstract][Full Text] [Related]
19. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
van Venrooij FV; Stolk RP; Banga JD; Sijmonsma TP; van Tol A; Erkelens DW; Dallinga-Thie GM;
Diabetes Care; 2003 Apr; 26(4):1216-23. PubMed ID: 12663600
[TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
